Note to Female Patients Of Reproductive Potential If 'None of the above' is Selected:
Please note that we strongly recommend that you use an effective method of contraception during treatment with a GLP-1 medication and for at least 2 months thereafter. For those taking Zepbound or Mounjaro (tirzepatide), we recommend switching to a non-oral contraceptive method or adding a barrier method of contraception for four weeks after initiation and for four weeks after each dose escalation. For any questions or concerns regarding your specific situation, please speak to your medical provider.